Jiangsu Nanfang Medical(SH:603880) Zhong Guo Jing Ying Bao·2025-08-13 12:31Core Viewpoint - Recent administrative penalties against the controlling shareholder and financial director of Nanwei Co., Ltd. highlight serious issues of insider trading and financial mismanagement within the company [1][2][4]. Group 1: Insider Trading Allegations - The controlling shareholder Li Ping and financial director Xiang Qinhua received a notice of administrative penalties for insider trading, with Li facing a confiscation of illegal gains amounting to 11.77 million yuan and a fine of 35.33 million yuan, while Xiang faces a confiscation of 101,700 yuan and a fine of 1.5 million yuan [1][2]. - Li Ping sold 8.184 million shares for 47.97 million yuan between March 14 and 28, 2023, while Xiang sold 54,000 shares for 340,500 yuan between March 21 and 22, 2023, both transactions occurring before the company was publicly warned of becoming a *ST stock [2][4]. Group 2: Financial Mismanagement - The company has faced multiple issues, including failure to disclose related party non-operating fund occupation and significant omissions in regular reports, leading to a warning and a fine of 3 million yuan from the Jiangsu Securities Regulatory Bureau [4]. - The company has reported continuous losses over the past four years, with net profits declining significantly, including a projected loss of 1.6 million to 1.2 million yuan for the first half of 2025 [6]. Group 3: Management Changes - Following the insider trading penalties, Xiang Qinhua resigned from her position as financial director, and Li Ping, who is also facing substantial fines, will temporarily assume her responsibilities [5][7].